These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9372115)

  • 1. The role of radioimmunotherapy in bone marrow transplantation.
    Corcoran MC; Press OW; Matthews DC; Appelbaum FR; Bernstein ID
    Curr Opin Hematol; 1996 Nov; 3(6):438-45. PubMed ID: 9372115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunotherapy of lymphomas and leukemias].
    Rain JD; Billotey C
    Pathol Biol (Paris); 1998 May; 46(5):341-5. PubMed ID: 9769896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunotherapy strategies for non-Hodgkin's lymphomas.
    Corcoran MC; Eary J; Bernstein I; Press OW
    Ann Oncol; 1997; 8 Suppl 1():133-8. PubMed ID: 9187447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in radioimmunotherapy for cancer.
    Meredith RF; LoBuglio AF; Spencer EB
    Oncology (Williston Park); 1997 Jul; 11(7):979-84, 987; discussion 987-8. PubMed ID: 9251118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclides as conditioning before stem cell transplantation.
    Jurcic JG; Scheinberg DA
    Curr Opin Hematol; 1999 Nov; 6(6):371-6. PubMed ID: 10546789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of radioimmunotherapy in the new millennium.
    Imam SK
    Cancer Biother Radiopharm; 2001 Jun; 16(3):237-56. PubMed ID: 11471488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
    Buchmann I; Bunjes D; Kotzerke J; Martin H; Glatting G; Seitz U; Rattat D; Buck A; Döhner H; Reske SN
    Cancer Biother Radiopharm; 2002 Apr; 17(2):151-63. PubMed ID: 12030109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of radioimmunoconjugates in stem cell transplantation.
    Pagel JM; Matthews DC; Appelbaum FR; Bernstein ID; Press OW
    Bone Marrow Transplant; 2002 May; 29(10):807-16. PubMed ID: 12058230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
    McGuire WP
    Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer.
    Hortobagyi GN
    Bone Marrow Transplant; 1988 Nov; 3(6):525-30. PubMed ID: 3063320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy for non-Hodgkin's lymphomas: a historical perspective.
    Press OW
    Semin Oncol; 2003 Apr; 30(2 Suppl 4):10-21. PubMed ID: 12728403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors.
    Savarese DM; Hsieh C; Stewart FM
    J Clin Oncol; 1997 Aug; 15(8):2981-95. PubMed ID: 9256143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.
    Behr TM; Wörmann B; Gramatzki M; Riggert J; Gratz S; Béhé M; Griesinger F; Sharkey RM; Kolb HJ; Hiddemann W; Goldenberg DM; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3304s-3314s. PubMed ID: 10541379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of leukemia with radiolabeled monoclonal antibodies.
    Sgouros G; Scheinberg DA
    Cancer Treat Res; 1993; 68():23-64. PubMed ID: 8105852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.
    Gustavsson A; Osterman B; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):605-19. PubMed ID: 14596518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy for treatment of B-cell lymphomas and other hematologic malignancies.
    Park SI; Press OW
    Curr Opin Hematol; 2007 Nov; 14(6):632-8. PubMed ID: 17898567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
    Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
    J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for developing effective radioimmunotherapy for solid tumors.
    DeNardo GL; O'Donnell RT; Kroger LA; Richman CM; Goldstein DS; Shen S; DeNardo SJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3219s-3223s. PubMed ID: 10541367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.